The SLC30A2 gene helps move zinc, an essential mineral, into storage areas inside cells and into breast milk. This gene plays an important role in helping a nursing baby get enough zinc for normal growth, skin health, and immune function. If you carry a harmful variant in the SLC30A2 gene, breast milk may contain too little zinc, which can lead to temporary zinc deficiency in a breastfed infant. The SLC30A2 gene is mainly known in medicine rather than popular culture.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which do much of the cells’ work. Others mainly determine when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. For a deeper look at this subject, you can find more in the LearnHub.
Overview
SLC30A2Gene function
What if the gene works
The SLC30A2 gene helps move zinc inside cells. It is especially important in the breast, where it helps place zinc into breast milk for a baby’s growth and development.
Risk
What if the gene does not work
Variants in the SLC30A2 gene can reduce zinc in breast milk, causing zinc deficiency in a breastfed infant. Effects can range from mild to severe, influencing how early symptoms appear and how much skin, growth, or digestive problems develop.
Treatment
What does that mean for your treatment
Loss-of-function variants in the SLC30A2 gene are managed with oral zinc for the infant during breastfeeding, because maternal zinc supplements do not reliably raise breast milk zinc. Formula feeding also avoids the low-zinc exposure. No other treatment tied to the SLC30A2 gene is established.
Gene function
What if the gene works
Your cells need carefully controlled zinc to keep many proteins working as they should. The SLC30A2 gene supports this by moving zinc into small compartments inside cells and into certain body fluids. This helps cells store, use, and release zinc in an organized way.
The SLC30A2 gene helps move zinc from the main cell fluid into small compartments inside cells. This gives cells a controlled way to place zinc where it is needed.
Its protein helps cells pack zinc into tiny packets used for storage or release. This supports normal work in cells that make and send out substances, such as gland cells.
In the breast, the SLC30A2 gene helps move zinc into milk during lactation (milk production). This is a key part of how the SLC30A2 gene supports normal breast milk zinc levels.
By shifting zinc away from the main cell fluid, this gene helps keep internal zinc levels balanced. That balance supports many proteins and enzymes that need zinc for everyday cell tasks.
What is a variant?
Genetic variants are small differences in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC30A2 gene can alter the zinc transporter’s shape, stability, or movement inside the cell, so less zinc gets loaded into the compartments that release it into breast milk. Some changes only partly reduce activity, while more severe variants can leave the protein unstable, misplaced, or largely nonworking. This range helps explain why SLC30A2 gene variants affecting zinc transport may cause milder or earlier infant symptoms in different families.
How variants are linked to conditions
Among the conditions linked to SLC30A2 gene variants, the best established is low zinc in breast milk causing transient neonatal zinc deficiency in a breastfed infant. Babies may develop a rash, diarrhea, irritability, or slower weight gain, while the breastfeeding parent often feels well. This is the main broadly confirmed condition associated with pathogenic variants in the SLC30A2 gene.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most of these variants do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also contribute. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC30A2 gene. In families with certain SLC30A2 changes, the main concern is low zinc in breast milk during breastfeeding, and risk is driven mostly by the gene change itself rather than lifestyle factors. Anyone worried about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of SLC30A2 variants
SLC30A2-related changes are usually inherited in an autosomal dominant pattern. In practical terms, this means a parent carrying a disease-causing variant in the SLC30A2 gene can pass it to a child with a 50% chance in each pregnancy. For families asking how SLC30A2 variants are inherited, the key point is that one altered copy can be enough to run in a family. This pattern is most often discussed when the variant affects zinc levels in breast milk, which can lead to low zinc exposure in a breastfed baby.
What does my SLC30A2 result mean for my family?
A disease-causing change in the SLC30A2 gene can run in families in a dominant pattern, so close relatives may also carry it. In practice, this matters most for female relatives, because some may produce breast milk with very low zinc and their breastfed babies could develop zinc deficiency. Parents, sisters, and adult children may want to share the result with their care team when planning for pregnancy or breastfeeding.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the SLC30A2 gene, genetic testing for the SLC30A2 gene uses a blood, saliva, or cheek swab sample. A laboratory reads the DNA sequence and checks for variants, then reports whether a change was found and how clearly its health meaning is understood.
When should I consider getting a genetic test?
Genetic testing for the SLC30A2 gene may be worth considering if a fully breastfed baby develops signs of low zinc, such as a rash, poor growth, or slow healing, especially with a family history of the same problem. A result can help explain low zinc in breast milk and guide care.
A genetic result is only one part of your health story
Genetic findings can be informative, yet how much they explain varies by the condition and the kind of variant involved. Over time, body function is also shaped by factors such as age, medical history, environment, and lifestyle. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with the rest of a person’s care. In other situations, a genetic result can offer a clear answer. In areas like medication response, it may also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body can absorb, break down, transport, or respond to drugs in different ways. These inherited differences are common and are one reason medication response can vary even when people take the same drug at the same dose. In some cases, this can influence how strongly a medicine works or how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. It studies gene-drug patterns to help explain why the same treatment may work differently in different people. For many drugs, genes can influence how strongly a medicine works or how the body handles it. This information can support treatment choices that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the SLC30A2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so questions about side effects, new symptoms, or how a treatment is working are best discussed with your doctor.
History
Throughout history, doctors described some breastfed infants who developed low zinc levels that improved with zinc treatment, even when the parent appeared healthy. Initially understood only through visible traits, later recognized as tied to a specific gene, this pattern became clearer in the late 20th and early 21st centuries as inherited causes of zinc transport problems were investigated. Researchers then linked some of these family cases to the SLC30A2 gene, helping explain why breast milk zinc levels could be unusually low in certain parents. From these first observations, research expanded steadily. Later studies identified different SLC30A2 variants in affected families and established the gene as part of the history of transient neonatal zinc deficiency.